N. Tanaka
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
- Hepatology top 10%
Papers in
- Co-authors
- Fumiko Mashige (1 shared paper)Sachiko Kamei (1 shared paper)Masami Yamanaka (1 shared paper)Toshiaki Osuga (5 shared papers)Junichi Shoda (4 shared papers)Hiroshi Miyazaki (3 shared papers)Yumi Matsuzaki (7 shared papers)Masahiko Tohma (2 shared papers)
- Journals
- Journal of Lipid Research (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Hepatology Research (2 papers)Inflammopharmacology (1 paper)Journal of Inherited Metabolic Disease (1 paper)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
N. Tanaka
26 papers receiving 693 citations
Peers
Comparison fields: 5 of 87
- Oncology 292
- Hepatology 76
- Pharmacology 66
- Clinical Biochemistry 46
- Cell Biology 84
Countries citing papers authored by N. Tanaka
This map shows the geographic impact of N. Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Tanaka more than expected).
Fields of papers citing papers by N. Tanaka
This network shows the impact of papers produced by N. Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Tanaka. The network helps show where N. Tanaka may publish in the future.
Co-authors
The 25 scholars most cited alongside N. Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 244 | |
| 2 | 1988 | 73 | |
| 3 | 1998 | 61 | |
| 4 | 2004 | 57 | |
| 5 | 1990 | 41 | |
| 6 | 2005 | 31 | |
| 7 | Instability of X chromosome methylation in aberrant crypt foci of the human colon. | 2000 | 28 |
| 8 | 1993 | 28 | |
| 9 | Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder. | 2001 | 24 |
| 10 | 1989 | 20 | |
| 11 | The effect of diet on hepatic bile formation and bile acid metabolism in squirrel monkeys with and without cholesterol gallstones. | 1976 | 18 |
| 12 | 2005 | 17 | |
| 13 | 2004 | 15 | |
| 14 | 2000 | 15 | |
| 15 | 1994 | 15 | |
| 16 | 1995 | 6 | |
| 17 | 2003 | 6 | |
| 18 | 2000 | 5 | |
| 19 | 1998 | 4 | |
| 20 | 2006 | 3 |
About N. Tanaka
N. Tanaka is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology, having authored 26 papers that have together received 723 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), T-cell and B-cell Immunology (2 papers), Tuberous Sclerosis Complex Research (2 papers), Metabolism and Genetic Disorders (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (292 citations), Hepatology (76 citations), Pharmacology (66 citations), Clinical Biochemistry (46 citations) and Cell Biology (84 citations). N. Tanaka has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Fumiko Mashige, Sachiko Kamei, Masami Yamanaka, Toshiaki Osuga, Junichi Shoda, Hiroshi Miyazaki, Yumi Matsuzaki, Masahiko Tohma, Reijiro Mahara and Kenji Matsuura. Their work appears in journals such as Journal of Lipid Research, International Journal of Radiation Oncology*Biology*Physics, Hepatology Research, Inflammopharmacology and Journal of Inherited Metabolic Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.